Huapont Life Sciences   Report issue

For profit Phase 3
Founded: Chongqing China (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2017
NCT02928094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now